Skip to main content
. 2023 Jan 26;2023(1):CD012144. doi: 10.1002/14651858.CD012144.pub3

Comparison 1. Short‐term prophylactic dose anticoagulation (start versus avoid).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Death 3 258 Risk Ratio (M‐H, Random, 95% CI) 1.00 [0.59, 1.70]
1.2 Deep vein thrombosis 3 260 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.49, 1.86]
1.3 Pulmonary embolism 4 333 Risk Ratio (M‐H, Random, 95% CI) 0.50 [0.22, 1.14]
1.4 Venous thromboembolism 4 333 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.51, 1.37]
1.5 Intracerebral haemorrhage 2 119 Risk Ratio (M‐H, Random, 95% CI) 0.24 [0.04, 1.38]
1.6 Major extracerebral haemorrhage 3 287 Risk Ratio (M‐H, Random, 95% CI) 2.77 [0.12, 65.82]
1.7 Growth of qualifying intracerebral haemorrhage 2 214 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.38, 2.41]
1.8 Functional status (modified Rankin Scale 0‐2) 1 73 Risk Ratio (M‐H, Fixed, 95% CI) 2.03 [0.78, 5.25]